Columbus, OH

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it sees continued high demand.

Lilly launches lower-price weight loss drug without injector pen

New York Post

Eli Lilly said it has started selling single-dose vials of its uber-popular weight-loss drug Zepbound as demand soars – and the smaller doses cost 50% less than rival drugs.

The more affordable vials are marketed toward patients whose health insurance will not reimburse them for weight-loss medications.

The drugmaker said it will sell 2.5 milligram and 5 milligram vials – now the two lowest doses of Zepbound – for $399 and $549 for a month’s supply on its website, LillyDirect. 



Lilly and its Danish rival Novo Nordisk have struggled to keep up with skyrocketing demand. 

Zepbound and Novo’s Wegovy have faced shortages for...

Eli Lilly slashes price of weight-loss drug Zepbound by 50% to sell in smaller doses

Eli Lilly is announcing a new way for people to get its popular Zepbound drug.

Eli Lilly to sell Zepbound directly to consumers without insurance coverage

Verywell Health

Several drugmakers are working on oral GLP-1s, offering people with obesity and overweight more options than the injectables on the market. Experts say oral options could help with supply issues, and possibly appeal to people who don’t like injections. Unless oral versions of GLP-1s are more affordable than injectables...

Would You Be More Likely to Take GLP-1s If They Came in Pill Form?

Original Medicare (parts A and B) does not cover all healthcare needs, including vision, hearing, and dental care. Medicare Advantage (Part C) plans may provide coverage for some of these services. Original Medicare includes Part A and Part B:. Medicare Part A (hospital insurance) helps pay for inpatient care you...

10 Healthcare Services Medicare Doesn’t Cover

Lucentis (ranibizumab) is a prescription drug used to treat certain eye conditions. It comes as a liquid solution for injection into your eye by an ophthalmologist. The typical dosing frequency is once per month. Lucentis injection is used in adults to treat:. wet age-related macular degeneration (AMD) macular edema after...

Dosage Details for Lucentis

Ozempic and Wegovy may have some new competition. Eli Lilly has announced that its new diabetes drug, Zepbound (tirzepatide), reduced the risk of developing Type 2 diabetes by 94% in prediabetic adults in a clinical trial. Additionally, treatment with tirzepatide resulted in sustained weight loss through the treatment period, with...

Eli Lilly says its new diabetes drug was 94% effective in clinical trials

The FDA approved Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older. The agency approved the first nasal spray formulation of nalmefene in May 2023. Drug overdose persists as a major public...

FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose

A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight used it weekly, it lowered their risk of progression to diabetes by 94% compared with a placebo, according to drugmaker Eli Lilly.

Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says

Eli Lilly (LLY) said Tuesday that the drug behind Zepbound was found to help nearly eliminate the risk of diabetes for adults who are pre-diabetic and are overweight or obese. The medication, tirzepatide, is sold by the company in the United States as Mounjaro for diabetes and Zepbound for weight loss.

Eli Lilly's weight loss drug almost eliminates the risk of diabetes in overweight adults

The rising cost of weight loss drugs has prompted many consumers to turn to sketchy websites that advertise the medications for a much lower price. However, many of these sites are actually illegal pharmacies, and consumers are often scammed for money, or receive the wrong kind of drug. In a...

Eli Lilly is offering weight loss drugs at a lower price point

Fox Business

Eli Lilly is launching more supply of its weight loss drug Zepbound. The new single-dose vials will be priced lower than "all other incretin GLP-1 medicines for obesity."

Eli Lilly cuts cost of certain Zepbound doses by at least 50%

Insider

People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease, per a three-year trial.

Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question

What treatments are available for management of pain and other fibromyalgia-related symptoms?. What do we know about efficacy of antidepressants, including SNRIs, in management of pain and other fibromyalgia symptoms?

Treatment option for fibromyalgia

Healthline

Learn about the various medications doctors use to treat different types of AML, including chemotherapy and newer targeted drugs.

What Medications Can Treat Acute Myeloid Leukemia (AML)?

WRTV

A four-week supply of 2.5-milligram (mg) vials is $399, and a four-week supply of 5-mg vials is $529, less than half the list price of other GLP-1 medicines for obesity, according to Eli Lilly.

New single-dose vials of weight-loss drug Zepbound available in the US

Scheduled toileting (or scheduled voiding) is a technique that people with overactive bladder (OAB) can use to help retrain their bladder. If you have OAB, you may often experience sudden urges to urinate. You may also urinate more frequently than usual, including during the night. The purpose of scheduled voiding is to get your bladder used to a regular frequency for urinating.

What to Know About Scheduled Toileting (Voiding) for Overactive Bladder

Insulet (Nasdaq:PODD) announced today that the FDA cleared its Omnipod 5 automated insulin delivery for use by people with type 2 diabetes. Clearance makes Omnipod 5, the company’s latest-generation AID system, the first and only such system cleared for type 1 and type 2 diabetes. Its indication covers those ages 18 and older in the type 2 population, while the system has been cleared for ages two and up in the type 1 bracket since 2022.

FDA clears Insulet Omnipod 5 for people with type 2 diabetes

LiveScience

Women with severe endometriosis are 10 times more likely to get ovarian cancer, while people with endometriosis of any severity are four times as likely, a study suggests. But patients shouldn't panic.

Endometriosis may quadruple risk of ovarian cancer, study finds

Colorado State

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

David Heitz

A bill quietly introduced this spring in the Colorado legislature to decriminalize the possession of drug paraphernalia obtained by harm reductionists has become law. As low-key as the legislation was introduced, the bill was signed into law without fanfare June 6. It garnered little to no media attention.

Colorado legalizes needles, pipes for meth and crack if obtained by harm reduction group

NewsBreak

Eli Lilly Cuts Zepbound Prices by 50% With Single-Dose Vials: What to Know

Eli Lilly officials announced a new program that provides consumers with single-dose vials of the weight-loss drug Zepbound at a discount price of 50% or more....

Eli Lilly Cuts Zepbound Prices by 50% With Single-Dose Vials: What to Know

Comments / 0